annual FCF:
-$232.83M-$47.76M(-25.81%)Summary
- As of today (September 19, 2025), VRDN annual free cash flow is -$232.83 million, with the most recent change of -$47.76 million (-25.81%) on December 31, 2024.
- During the last 3 years, VRDN annual FCF has fallen by -$177.91 million (-323.95%).
- VRDN annual FCF is now -19749.10% below its all-time high of -$1.17 million, reached on December 31, 2013.
Performance
VRDN Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$75.42M+$17.32M(+18.68%)Summary
- As of today (September 19, 2025), VRDN quarterly free cash flow is -$75.42 million, with the most recent change of +$17.32 million (+18.68%) on June 30, 2025.
- Over the past year, VRDN quarterly FCF has dropped by -$29.25 million (-63.37%).
- VRDN quarterly FCF is now -35846.14% below its all-time high of -$209.80 thousand, reached on December 1, 2012.
Performance
VRDN quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$309.60M-$29.25M(-10.43%)Summary
- As of today (September 19, 2025), VRDN TTM free cash flow is -$309.60 million, with the most recent change of -$29.25 million (-10.43%) on June 30, 2025.
- Over the past year, VRDN TTM FCF has dropped by -$140.78 million (-83.39%).
- VRDN TTM FCF is now -147468.64% below its all-time high of -$209.80 thousand, reached on December 1, 2012.
Performance
VRDN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
VRDN Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.8% | -63.4% | -83.4% |
| 3 y3 years | -323.9% | -310.4% | -353.4% |
| 5 y5 years | -544.2% | -1010.8% | -857.4% |
VRDN Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -323.9% | at low | -310.4% | +18.7% | -353.4% | at low |
| 5 y | 5-year | -680.8% | at low | -1364.9% | +18.7% | -997.8% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +18.7% | <-9999.0% | at low |
VRDN Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$75.42M(-18.7%) | -$309.60M(+10.4%) |
| Mar 2025 | - | -$92.74M(+26.3%) | -$280.35M(+20.4%) |
| Dec 2024 | -$232.83M(+25.8%) | -$73.45M(+8.0%) | -$232.83M(+17.9%) |
| Sep 2024 | - | -$68.00M(+47.3%) | -$197.43M(+16.9%) |
| Jun 2024 | - | -$46.16M(+2.1%) | -$168.82M(+0.4%) |
| Mar 2024 | - | -$45.22M(+18.9%) | -$168.20M(-9.1%) |
| Dec 2023 | -$185.07M(+95.6%) | -$38.05M(-3.4%) | -$185.07M(+25.9%) |
| Sep 2023 | - | -$39.39M(-13.5%) | -$147.02M(+36.6%) |
| Jun 2023 | - | -$45.55M(-26.6%) | -$107.63M(+33.8%) |
| Mar 2023 | - | -$62.09M(+237.8%) | -$80.47M(+17.8%) |
| Dec 2022 | -$94.64M(+72.3%) | - | - |
| Jun 2022 | - | -$18.38M(-13.4%) | -$68.28M(+5.7%) |
| Mar 2022 | - | -$21.22M(+27.7%) | -$64.59M(+17.6%) |
| Dec 2021 | -$54.92M(+84.2%) | -$16.62M(+37.8%) | -$54.92M(+15.1%) |
| Sep 2021 | - | -$12.06M(-17.9%) | -$47.73M(+16.9%) |
| Jun 2021 | - | -$14.69M(+27.1%) | -$40.81M(+24.0%) |
| Mar 2021 | - | -$11.55M(+22.6%) | -$32.92M(+10.4%) |
| Dec 2020 | -$29.82M(-17.5%) | -$9.43M(+83.1%) | -$29.82M(+5.7%) |
| Sep 2020 | - | -$5.15M(-24.2%) | -$28.20M(-12.8%) |
| Jun 2020 | - | -$6.79M(-19.7%) | -$32.34M(-1.3%) |
| Mar 2020 | - | -$8.46M(+8.4%) | -$32.75M(-9.4%) |
| Dec 2019 | -$36.14M | -$7.81M(-15.9%) | -$36.14M(-1.1%) |
| Sep 2019 | - | -$9.28M(+28.8%) | -$36.56M(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$7.21M(-39.2%) | -$34.28M(+8.2%) |
| Mar 2019 | - | -$11.85M(+44.0%) | -$31.68M(+16.1%) |
| Dec 2018 | -$27.29M(-4.0%) | -$8.23M(+17.4%) | -$27.29M(+3.6%) |
| Sep 2018 | - | -$7.01M(+52.3%) | -$26.34M(+5.1%) |
| Jun 2018 | - | -$4.60M(-38.3%) | -$25.06M(-9.3%) |
| Mar 2018 | - | -$7.46M(+2.5%) | -$27.64M(-2.7%) |
| Dec 2017 | -$28.41M(+292.8%) | -$7.28M(+27.1%) | -$28.41M(+16.3%) |
| Sep 2017 | - | -$5.73M(-20.3%) | -$24.43M(-6.7%) |
| Jun 2017 | - | -$7.18M(-12.7%) | -$26.18M(+24.6%) |
| Mar 2017 | - | -$8.23M(+149.5%) | -$21.01M(+40.0%) |
| Dec 2016 | -$7.23M(+3.0%) | -$3.30M(-55.9%) | -$15.01M(+15.2%) |
| Sep 2016 | - | -$7.47M(+272.3%) | -$13.03M(+65.1%) |
| Jun 2016 | - | -$2.01M(-9.8%) | -$7.89M(-2.5%) |
| Mar 2016 | - | -$2.23M(+68.3%) | -$8.09M(+15.3%) |
| Dec 2015 | -$7.02M(+183.2%) | -$1.32M(-43.4%) | -$7.02M(+0.9%) |
| Sep 2015 | - | -$2.34M(+5.7%) | -$6.96M(+27.6%) |
| Jun 2015 | - | -$2.21M(+91.7%) | -$5.45M(+68.2%) |
| Mar 2015 | - | -$1.15M(-8.4%) | -$3.24M(+55.2%) |
| Dec 2014 | -$2.48M(+111.3%) | -$1.26M(+51.4%) | -$2.09M(+75.4%) |
| Sep 2014 | - | -$831.00K(+130.8%) | -$1.19M(+230.8%) |
| Dec 2013 | -$1.17M(-81.5%) | -$360.10K(+71.6%) | -$360.10K(+71.6%) |
| Dec 2012 | -$6.33M | - | - |
| Dec 2012 | - | -$209.80K | -$209.80K |
FAQ
- What is Viridian Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual FCF year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Viridian Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM FCF year-on-year change?
What is Viridian Therapeutics, Inc. annual free cash flow?
The current annual FCF of VRDN is -$232.83M
What is the all time high annual FCF for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual free cash flow is -$1.17M
What is Viridian Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, VRDN annual free cash flow has changed by -$47.76M (-25.81%)
What is Viridian Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of VRDN is -$75.42M
What is the all time high quarterly FCF for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly free cash flow is -$209.80K
What is Viridian Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, VRDN quarterly free cash flow has changed by -$29.25M (-63.37%)
What is Viridian Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of VRDN is -$309.60M
What is the all time high TTM FCF for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM free cash flow is -$209.80K
What is Viridian Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, VRDN TTM free cash flow has changed by -$140.78M (-83.39%)